Repligen | RGEN - Cost Of Sales

Repligen reported $90.7M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Agilent A:US USD 788M 49M
Align Technology ALGN:US USD 283.81M 12.64M
Bio Techne TECH:US USD 88.22M 1.84M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Bruker BRKR:US USD 342.5M 38.7M
Catalent CTLT:US USD 762M 2M
Charles River Laboratories CRL:US USD 700.96M 82.02M
Danaher DHR:US USD 3.43B 351M
Dentsply International XRAY:US USD 466M 27M
Exact Sciences EXAS:US USD 147.15M 785K
Fluidigm FLDM:US USD 15.85M 572K
General Electric GE:US USD 15.88B 1.22B
Henry Schein HSIC:US USD 2.37B 219M
Illumina ILMN:US USD 411M 13M
IQVIA Holdings Inc IQV:US USD 2.41B 86M
Mettler Toledo International MTD:US USD 425.54M 24.36M
Myriad Genetics MYGN:US USD 53.9M 3.5M
Nanostring Technologies NSTG:US USD 21.12M 7.4M
Orasure Technologies OSUR:US USD 73.49M 3.22M
Pacific Biosciences Of California PACB:US USD 18.51M 256K
Patterson Companies PDCO:US USD 1.26B 40.23M
Peregrine Pharmaceuticals PPHM:US USD 28.19M 2.42M
Perkinelmer PKI:US USD 304.88M 125K
Pfizer PFE:US USD 9.82B 3.73B
Repligen RGEN:US USD 90.7M 4.19M
Thermo Fisher Scientific TMO:US USD 6.72B 340M
Waters WAT:US USD 348.19M 41.09M
West Pharmaceutical Services WST:US USD 446.6M 27.7M